<table width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 13. Established and Other Potentially Significant Drug Interactions</caption>
<colgroup>
<col width="34%"></col>
<col width="33%"></col>
<col width="33%"></col>
</colgroup>
<thead>
<tr stylecode="First Last">
<td align="center" stylecode="Botrule Lrule Rrule Toprule" valign="top">Concomitant Drug</td>
<td align="center" stylecode="Botrule Lrule Rrule Toprule" valign="top">Effect on Concentration of Lamotrigine or  <br/>Concomitant Drug</td>
<td align="center" stylecode="Botrule Lrule Rrule Toprule" valign="top">Clinical Comment </td>
</tr>
</thead>
<tfoot>
<tr stylecode="First Last">
<td align="left">
<paragraph></paragraph>
<paragraph stylecode="Footnote">↓= Decreased (induces lamotrigine gluronidation).</paragraph>
<paragraph stylecode="Footnote">↑= Increased (inhibits lamotrigine glucuronidation).</paragraph>
<paragraph stylecode="Footnote">?= Conflicting data.</paragraph>
</td>
</tr>
</tfoot>
<tbody>
<tr>
<td align="left" stylecode="Lrule Rrule Toprule" valign="top">Estrogen-containing oral <br/>contraceptive preparations <br/>containing 30 mcg ethinylestradiol <br/>and 150 mcg levonorgestrel</td>
<td align="center" stylecode="Lrule Rrule Toprule" valign="top">↓ lamotrigine<br/>
<br/>
<br/>
<br/>
</td>
<td align="center" stylecode="Lrule Rrule Toprule" valign="top">Decreased lamotrigine levels <br/>approximately 50%.<br/>
<br/>
<br/>
</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule" valign="top"></td>
<td align="center" stylecode="Botrule Lrule Rrule" valign="top">↓ levonorgestrel</td>
<td align="center" stylecode="Botrule Lrule Rrule" valign="top">Decrease in levonorgestrel component by 19%.</td>
</tr>
<tr>
<td align="left" stylecode="Lrule Rrule Toprule" valign="top">Carbamazepine (CBZ) and <br/>CBZ epoxide</td>
<td align="center" stylecode="Lrule Rrule Toprule" valign="top">↓ lamotrigine<br/>
</td>
<td align="center" stylecode="Lrule Rrule Toprule" valign="top">Addition of carbamazepine decreases lamotrigine <br/>concentration approximately 40%.<br/>
</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule" valign="top"></td>
<td align="center" stylecode="Botrule Lrule Rrule" valign="top">? CBZ epoxide</td>
<td align="center" stylecode="Botrule Lrule Rrule" valign="top">May increase CBZ epoxide levels</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule Toprule" valign="top">Phenobarbital/Primidone</td>
<td align="center" stylecode="Botrule Lrule Rrule Toprule" valign="top">↓ lamotrigine</td>
<td align="center" stylecode="Botrule Lrule Rrule Toprule" valign="top">Decreased lamotrigine <br/>concentration approximately 40%.</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule Toprule" valign="top">Phenytoin (PHT)</td>
<td align="center" stylecode="Botrule Lrule Rrule Toprule" valign="top">↓ lamotrigine</td>
<td align="center" stylecode="Botrule Lrule Rrule Toprule" valign="top">Decreased lamotrigine <br/>concentration approximately 40%</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule Toprule" valign="top">Rifampin</td>
<td align="center" stylecode="Botrule Lrule Rrule Toprule" valign="top">↓ lamotrigine</td>
<td align="center" stylecode="Botrule Lrule Rrule Toprule" valign="top">Decreased lamotrigine AUC <br/>approximately 40%</td>
</tr>
<tr>
<td align="left" stylecode="Lrule Rrule Toprule" valign="top">Valproate</td>
<td align="center" stylecode="Lrule Rrule Toprule" valign="top">↑ lamotrigine<br/>
</td>
<td align="center" stylecode="Lrule Rrule Toprule" valign="top">Increased lamotrigine concentrations slightly <br/>more than 2-fold.<br/>
</td>
</tr>
<tr>
<td align="left" stylecode="Botrule Lrule Rrule" valign="top"></td>
<td align="center" stylecode="Botrule Lrule Rrule" valign="top">? valproate</td>
<td align="center" stylecode="Botrule Lrule Rrule" valign="top">Decreased valproate concentrations an average of <br/>25% over a 3-week period then stabilized in healthy volunteers; <br/>no change in controlled clinical trials in epilepsy patients.<br/>
</td>
</tr>
</tbody>
</table>